Malaria Respiratory Diseases Cancer HIV Proteome Bioterrorism Antidotes Multiple Sclerosis Methodology CJD

Cancer is widely feared and continues to affect a large number of people. Almost everyone knows someone who has suffered from cancer. While there have been significant improvements in the diagnosis of cancer, and some new treatments, there are still too many forms of cancer which can be fatal and in many cases the available treatments are unpleasant and too often ineffective.

In collaboration with the University of Oxford, the National Foundation for Cancer Research (NFCR) and United Devices, Treweren Consultants made its THINK software available for the first large scale virtual screening project, which was sponsored by Intel. The first phase of this project evaluated approximately 3.5 billion molecules against 12 protein targets. In this follow-on project, more protein targets are being evaluated using the latest release of the THINK software.